Invasive management of non-ST elevation MI in patients with chronic kidney disease leads to better survival outcomes than conservative treatment, new research shows.

Those offered invasive therapy also had “minimal” increased risk of in-hospital acute kidney injury requiring dialysis and major bleeding, according to US researchers.

Study first author, interventional cardiologist Dr Ankur Kalra, said the results would likely influence clinical decision-making and the development of treatment guidelines for non-ST elevation MI (NSTEMI) in this population.

In a real-world analysis, Dr Kalra, from Indiana University School of Medicine in Indianapolis, and colleagues analysed clinical outcomes in 141,000 older adults with NSTEMI and chronic kidney disease (CKD) stage 3-5 or end-stage kidney disease (ESKD).